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Abstract
Background: Mammalian transcriptomes contain thousands of long noncoding RNAs (lncRNAs). Some lncRNAs
originate from intragenic enhancers which, when active, behave as alternative promoters producing transcripts that
are processed using the canonical signals of their host gene. We have followed up this observation by analyzing
intergenic lncRNAs to determine the extent to which they might also originate from intergenic enhancers.
Results: We integrated high-resolution maps of transcriptional initiation and transcription to annotate a conservative
set of intergenic lncRNAs expressed in mouse erythroblasts. We subclassified intergenic lncRNAs according to
chromatin status at transcriptional initiation regions, defined by relative levels of histone H3K4 mono- and
trimethylation. These transcripts are almost evenly divided between those arising from enhancer-associated
(elncRNA) or promoter-associated (plncRNA) elements. These two classes of 5′ capped and polyadenylated RNA
transcripts are indistinguishable with regard to their length, number of exons or transcriptional orientation relative to
their closest neighboring gene. Nevertheless, elncRNAs are more tissue-restricted, less highly expressed and less well
conserved during evolution. Of considerable interest, we found that expression of elncRNAs, but not plncRNAs, is
associated with enhanced expression of neighboring protein-coding genes during erythropoiesis.
Conclusions: We have determined globally the sites of initiation of intergenic lncRNAs in erythroid cells, allowing
us to distinguish two similarly abundant classes of transcripts. Different correlations between the levels of
elncRNAs, plncRNAs and expression of neighboring genes suggest that functional lncRNAs from the two classes
may play contrasting roles in regulating the transcript abundance of local or distal loci.
Background
Eukaryotic genomes are pervasively transcribed [1,2] with
evidence for up to three-quarters of nucleotides in the
human genome being expressed in at least one cell type
during development [2]. Transcripts lacking an apparent
open reading frame are often classified simply based on
their length, the absence of protein-coding potential and
their location in the genome relative to protein-coding
genes [3,4]. An intriguing class of noncoding transcripts are
those exceeding 200 nucleotides in length and transcribed
from loci that are intergenic relative to protein-coding
genes (intergenic long noncoding RNAs (lncRNAs)). At
least 50,000 lncRNAs are expressed from intergenic regions
of the human genome, more than twice the number of
protein-coding genes [5]. Compared to protein-coding
transcripts, intergenic lncRNAs are generally less abundant
and their expression is more spatially and temporally
restricted [4,6]. Genome-wide analysis of mammalian
intergenic lncRNA sequence [7,8] and transcription [9,10]
has revealed that, in general, these loci have been conserved
during evolution, albeit at substantially lower levels
than protein-coding genes, suggesting that at least some
intergenic lncRNAs may have conserved biological roles.
Biological functions attributed to the handful of well-
characterized intergenic lncRNAs are diverse, ranging from
transcriptional control to post-transcriptional modulation
of gene expression (for recent reviews see [11-13]).
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lncRNAs as those that are transcribed by RNA-polymerase
II, 5′ end capped and polyadenylated. Here we address
two important, and incompletely answered, questions
concerning the origins (transcriptional initiation regions
(TIRs)) and classification of intergenic lncRNAs. First,
what is the relative prevalence of promoter- and enhancer-
associated transcripts within sets of transcripts that are
annotated simply as being intergenic lncRNAs? Second,
do differences in the chromatin status at intergenic lncRNA
TIRs reflect their potential function?
Histone modifications allow the distinction between
different types of regulatory elements [14,15]. Promoters
of transcribed protein-coding genes, for example, are
enriched in trimethylation of lysine 4 of histone H3
(H3K4me3) [14,15]. Some intergenic lncRNA loci have
been defined previously using chromatin signatures that
are similar to those often found at protein-coding genes,
namely H3K4me3 marked promoters and trimethylation
of lysine 36 of histone H3 (H3K36me3) across transcribed
regions [16]. These findings demonstrate that some
intergenic lncRNAs are transcribed from promoter-like
elements.
A second class of transcripts could be prevalent
in current catalogues of intergenic lncRNAs, namely
enhancer-associated noncoding RNAs (eRNAs) [17].
Transcription is a common feature of active mammalian
enhancers and can give rise to both non-polyadenylated,
bidirectional, unstable transcripts [17] as well as unidirec-
tionally transcribed, polyadenylated, relatively stable and
sometimes spliced eRNAs [18,19]. We have previously
s h o w nt h a ta c t i v a t i o no fe n h a n c e r sl o c a t e dw i t h i np r o t e i n -
coding genes promotes transcription of long noncoding
RNAs that utilize splicing and polyadenylation signals from
their protein-coding hosts to produce stable unidirectional
eRNAs [20]. On the other hand, the expression of inter-
genic lncRNA loci has been associated with enhanced levels
of their neighboring protein-coding genes, both through
genome-wide [10,21,22] and locus-specific analyses [22,23],
suggesting that a large, yet undetermined, fraction of
transcripts within lncRNA catalogues are unidirectional
eRNAs, as previously proposed by Natoli and Andrau
[24]. These observations motivated us to expand on our
earlier observations [10,20] to determine to what extent
intergenic lncRNAs might originate from active intergenic
enhancers.
To address this question we generated new genome-wide
maps of H3K4me3 and monomethylation of lysine 4 of
histone H3 (H3K4me1 and H3K4me3, respectively), deep
poly(A)+RNA sequencing and nanoCAGE [25,26] data
from purified mouse erythroblasts. Using these data, we
annotated a stringent set of intergenic lncRNAs expressed
in these cells and accurately defined their transcriptional
start sites using these newly acquired nanoCAGE data. We
used the relative abundance of H3K4me1 and H3K4me3
at these intergenic lncRNAs’ TIRs, a well-established and
widely used approach to differentiate between promoter
and enhancer-like regulatory elements [27], to distinguish
unidirectional eRNAs (here called elncRNAs) from
promoter-associated lncRNAs (or plncRNAs). Our analyses
demonstrate that chromatin marks at their TIRs effectively
separate two equally prevalent classes of intergenic lncRNAs.
These classes differ with respect to their evolution,
tissue-specificity, levels of expression and co-expression
levels with their neighboring genes, suggesting that, if
they influence gene expression, they may do so in different
ways.
Results
More than half of lncRNAs originate from
enhancer-like regions
The functional cis-elements, trans-acting factors and epi-
genetic modifications associated with gene expression
during the well-defined cellular stages of erythropoiesis
have been studied extensively [28-30]. This molecular
and cellular model is thus ideal for studying the causes
and potential consequences of lncRNA transcription.
We used nanoCAGE [26] to capture and sequence
the 5′ ends of purified mouse (C57BL/6 J) intermediate
erythroblast expressed transcripts and to annotate their
TIRs in these cells. We defined TIRs as previously [25] by
clustering the 5′ end positions of reads mapping within 20
nucleotides on the same strand. Clusters closer than 400
nucleotides were then considered to be part of the same
TIR (Materials and methods). Integrating nanoCAGE and
paired-end transcription (RNA-Seq) data allowed us to
identify 11,689 polyadenylated transcripts (Additional
file 1) originating from 7,608 TIRs that overlap DNase 1
hypersensitive sites in mouse intermediate erythroblasts
(Materials and methods; Additional files 2 and 3). As
expected [31], the nanoCAGE read count supporting a
given TIR correlates well (Pearson R= 0.44) with the
expression level of its associated transcript (Additional
file 4). Most (95.4%) transcripts overlap by one or more
nucleotides a protein-coding gene annotation (ENSEMBL
b u i l d6 8[ 3 2 ] )a n df o rs i m p l i c i t yw er e f e rt ot h e s ea s
protein-coding transcripts. Of the remaining intergenic
transcripts, 391 had no protein-coding potential [33] and
were longer than 200 nucleotides and thus were annotated
as being lncRNAs. A small, but significant (6; 36-fold
enrichment, P<1×1 0
-3; Materials and methods), number
of these lncRNAs were also identified as being expressed
in erythroblasts in an earlier experiment [28]. Differences
between the two catalogues are likely due to the use of
different experimental methods (RNA hybridization or
sequencing) and the conservative approach used in the
current study to annotate intergenic lncRNA transcripts.
Indeed, when we considered overlapping RNAseq reads to
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previously reported lncRNAs found to be expressed in
mouse intermediate erythroblasts [28] were identified as
expressed in our experiment.
To classify TIRs associated with these annotations
we used genome-wide chromatin immunoprecipitation
followed by sequencing (ChIP-seq) to identify regions en-
riched in H3K4me1 or H3K4me3 (Materials and methods).
A relatively high level of H3K4me1- over H3K4me3-
modified chromatin is a well-established property of
enhancers [20,34,35] that has been extensively used to gen-
erate genome-wide catalogues of enhancer- or promoter-
like regulatory elements [36]. Here we generated DNase-Seq
data to identify all active regions within the genome
and then quantified these regions’ relative enrichment
of H3K4me1 and H3K4me3. On the basis of their differ-
ence in these marks, active elements were then effectively
sorted into two clearly demarcated classes (Additional
file 5) that show characteristics of either promoters or
enhancers [20]. In such a way TIRs were classified as
either enhancer-like (H3K4me1
high, 686 TIRs) or promoter-
like (H3K4me3
high, 6824 TIRs) (Additional file 6). As
expected, these regions are enriched in acetylation of
lysine 27 of histone 3 (H3K27ac; Figure 1; Additional
file 5), a well-accepted mark of biological activity.
As expected, most (92%) protein-coding transcripts
initiate at promoter-like TIRs (Figure 1A). The 568 protein-
coding transcripts originating from enhancer-like TIRs
(Figure 1A) substantially overlap our previously reported
set [20] of 176 enhancer-associated alternative first exons
identified in this cell-type (5.7-fold enrichment, permuta-
tion test P<10
-3). Of the top 15 enhancer-associated
protein-coding transcripts, 12 correspond to enhancer-
associated intragenic lncRNAs (meRNAs) identified in
our previous study [20], including 2 meRNAs initiating
at the α-globin enhancers (Additional file 7).
Next we considered the set of 391 TIRs associated with
lncRNA expression. Consistent with an earlier report [37],
more than a third of lncRNAs (152, 38%) are transcribed
from bidirectional, protein-coding gene TIRs. The chro-
matin associated with most (97%) bidirectional TIRs is
enriched with H3K4me3. These lncRNAs were not
considered further in this analysis. Hereafter we refer
to the 239 lncRNAs that are entirely intergenic (that is,
they overlap neither protein-coding genes nor their TIRs)
as intergenic lncRNAs. In contrast to protein-coding genes,
more than half (124, 52%) of these lncRNAs originate at
enhancer-like rather than at promoter-like TIRs (Figure 1B;
Additional file 8). We refer to these transcripts as intergenic
enhancer-associated lncRNAs or elncRNAs (Figure 1D).
The remaining 115 intergenic lncRNAs arise from pro-
moter-like TIRs, and hence we refer to these as intergenic
promoter-associated lncRNAs or plncRNAs (Figure 1C;
Additional file 9). It has previously been shown that many
active erythroid enhancers are bound by the tissue-
restricted transcription factor Gata1 [29,38]. Consistent
with this, we found an enrichment of Gata1 binding at the
TIRs of elncRNAs but not plncRNAs (Figure 1A,B).
Comparisons of the sequence features of elncRNA and
plncRNA transcripts
To address whether differences in histone marks at their
origin reflect differences in the properties of elncRNAs
and plncRNAs, we next investigated their sequence
features. The TIR sizes and transcript lengths of both
classes of lncRNAs (Figure 2A,B) are similar, as are the
fractions of multiexonic transcripts within each class
(Figure 2C). Therefore these sequence features do not
permit the distinction of elncRNAs from plncRNAs.
We also determined the orientation of transcription of
plncRNAs and elncRNAs relative to their closest protein-
coding genes (Figure 2D). Both elncRNAs and plncRNAs
are preferentially transcribed in the opposite direction to
that of their nearest protein coding neighbors. We noted a
non-significant trend for plncRNAs, relative to elncRNAs,
and their closest protein-coding genes to lie in a head-
to-head orientation (Figure 2E). Probably, as a consequence,
the TIRs of plncRNAs and their protein-coding gene
neighbors (median =29.6 kb) are significantly closer to each
other than are the TIRs of elncRNAs and their adjacent
protein-coding genes (median=44.1 kb) or are pairs of
protein-coding genes (median=48.5 kb; Additional file 10).
Also, the density of poly(A)-selected reads mapped around
elncRNA and plncRNA transcriptional start sites revealed
that, in terms of directionality, the two classes of lncRNAs
are predominantly unidirectional and indistinguishable
from each other or protein-coding transcripts (Figure 2F).
A similar analysis using poly(A)-depleted RNA sequencing
reads revealed that their TIRs exhibit similar signatures to
those previously described for promoter- and enhancer-like
elements, as expected [2,17] (Additional file 11).
elncRNAs and plncRNAs have different origins
and different patterns of expression
Next we investigated the DNA sequence underlying the
TIRs of intergenic lncRNAs. It has previously been shown
that transposable elements are enriched both at enhancer
elements [39] and at the promoters of intergenic lncRNAs
[40,41]. Here we find more specifically that the cover-
a g eo ft r a n s p o s a b l ee l e m e n t -derived TIRs by transpos-
able element sequence is higher for elncRNAs (median
density= 0.4, two-tailed Mann–Whitney test, P<0.002)
than for plncRNAs (median density= 0.23) loci (Figure 3A).
Short interspersed nuclear elements (SINEs) are particu-
larly highly associated with elncRNA TIRs (40% higher,
permutation test, P<0.01). Intergenic enhancers that are
unidirectionally transcribed are rarely associated with CpG
islands [19] and in agreement we found that none (0) of
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islands. By contrast, nearly half (48%, 66) of plncRNA
TIRs overlap a CpG island (>1 nucleotide), a significantly
higher fraction (P<0.001, two-tailed Fisher’s exact test).
The different origins of elncRNAs’ and plncRNAs’ TIRs
suggest that these lncRNAs may have different patterns
of expression and, if functional, may play different roles.
During this manuscript’s preparation Schlesinger et al.
[42] also proposed that CpG density might allow the
distinction of transcribed promoter- from enhancer-like
regions.
To determine how intergenic elncRNAs and plncRNAs
are expressed throughout differentiation and development
we used Cufflinks [43] to estimate their abundance
(fragments per kilobase of sequence per million reads
(FPKM)) in intermediate erythroblasts, in normal adult
tissues and in cell lines for which data are publicly
available [44] (Additional file 12). To estimate cell specifi-
city, we identified the tissue in which each transcript
is most highly expressed and then estimated the fold
increase in expression in that tissue relative to its median
expression across all tissues tested (maximum tissue speci-
ficity, max Ts). As observed previously [4,6], in intermediate
erythroblasts, intergenic lncRNAs are, on average, two
times more tissue specific and ten-fold less abundant
than protein-coding transcripts (data not shown). The
comparison between intergenic lncRNA classes revealed
that elncRNAs tend to have a more restricted pattern of
expression (Figure 3B) and are less abundant in intermedi-
ate erythroblasts than plncRNAs (Figure 3C). Consistent
with their lower abundance and restricted expression, we
found that 88% (110) of the elncRNAs identified here
are novel (that is, they show no overlap with ENSEMBL
lncRNA transcripts). This fraction is significantly higher
Figure 1 Contrasting epigenetic landscapes at transcriptional start sites for protein-coding genes and lncRNAs in mouse intermediate
erythroblasts. The heatmap represents the distribution of DNAse I hypersensitive sites (DHS), H3K4me1, H3K4me3, H3K27ac, Gata1 and
NanoCAGE signal (red high, green low) in a 4 kbp window centered around the middle of the nanoCAGE-defined TIRs for (A) protein-coding
genes and (B) lncRNA loci. Representative novel (C) elncRNA (green, chr12:112754628 to 112804627 (mm9)) and (D) plncRNA (blue,
chr9:72229000 to 72364999 (mm9)) were annotated de novo from C57BL/6 erythroid cell poly(A)+RNA (brown). Their transcriptional start sites
were defined using strand-specific nanoCAGE (red; plus and minus signs represent density of reads within strand-specific libraries) found within
DHS regions (grey). H3K4me1, green; H3K4me3, blue. Arrows on elncRNA and plncRNA and their neighboring transcript indicate the direction
of transcription.
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Figure 2 elncRNA and plncRNA loci have similar sequence features. (A) The lengths of elncRNA (enh-TIR, median=293 nucleotide, green)
and plncRNA (prom-TIR, median=342 nucleotide, blue) TIRs are similar (two-tailed Mann–Whitney test, P= 0.52), (B) as are the lengths of
elncRNA (median= 1006 nucleotide) and plncRNA (median= 903 nucleotide) transcripts (two-tailed Mann–Whitney test, P=0.24). (C) The
percentage of elncRNAs that are mono-exonic (47%, dark green) is similar to that for plncRNAs (54%, dark blue, two-tailed Fisher’s exact test,
P=0.37). Light green and blue represent the percentage of multiexonic elncRNAs and plncRNAs, respectively. (D) Relative transcriptional orientation
for lncRNAs (black) and their closest protein-coding gene (grey). For simplicity lncRNAs are represented here as transcribed from 5′ to 3′.
Arrow represents the direction of transcription. (E) Percentages of lncRNA-protein-coding gene pairs with relative orientation head-to-head
(white; elncRNAs=31%, plncRNAs=41%); tail-to-tail (light-grey, elncRNAs =45%, plncRNAs=35%); tail-to-head (dark-grey; elncRNAs =19%,
plncRNAs=14%) and head-to-tail (black; elncRNAs=5%, plncRNAs=10%). (F) Total number of polyA selected RNA sequencing reads (y-axis)
associated with the transcriptional start sites of protein-coding gene (black), elncRNA (green) and plncRNA (blue) meta-genes’ transcriptional start sites
(±50 bp, x-axis). Arrow indicates the location of the transcriptional start site and the direction of the meta-gene transcription. NS, not significant.
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annotated (65, two-tailed Fisher’s exact test, P <0.001).
elncRNA sequence is not constrained during
mammalian evolution
Evolutionary constraint should reflect conservation of func-
tion and therefore we assessed this for intergenic elncRNAs
and plncRNAs by comparing the nucleotide substitution
rates at their TIRs in rodents. We estimated these rates by
comparing the substitutions in aligned mouse and rat TIR
sequences with the corresponding rate at neighboring
(presumed neutrally evolving) sequence with matching
G+C content (Materials and methods, dneutral)[ 8 ] .T h e
substitution rate of promoter-like TIRs was significantly
lower (20% on average; two-tailed Mann–Whitney test,
P <1×1 0
-14; Figure 4A) than the proxy neutral rate. By
contrast, the substitution rate for enhancer-like TIRs was
not significantly different from the neutral rate (two-tailed
Mann–Whitney test, P=0.35; Figure 4A).
Next we investigated the evolutionary signatures, in the
two rodents, across the full length (exons and introns)
of elncRNA or plncRNA loci. Consistent with the lack
of detectable evolutionary constraint at their respective
TIRs, we found that elncRNA loci accumulate substitutions
at the same rate as neighboring neutrally evolving sequence
(two-tailed Mann–Whitney test, P = 0.24; Figure 4B).
By contrast, we found plncRNA loci to be selectively
constrained (two-tailed Mann–Whitney test, P <0 . 0 5 ;
Figure 4B), accumulating on average 5% fewer substitutions
per nucleotide than neutral sequence. This is consist-
ent with negative selection purging a small number of
deleterious mutations at these loci. To determine whether
it is transcription across the loci or the plncRNA transcript
per se that has been the subject of constraint during rodent
evolution, we compared the substitution rates of plncRNA
introns and exons. We found that plncRNA exons (two-
tailed Mann–Whitney test, P<0.01; Figure 4C) but not
introns (two-tailed Mann–Whitney test, P=0 .1 9;Figure4 C)
were selectively constrained. This suggests that when
plncRNAs are functional, their functions can be conserved
and will more often be transacted by mature rather than
by unspliced transcripts than through the act of transcrip-
tion per se. Neither elncRNA exons nor their introns ex-
hibited non-neutral evolution (two-tailed Mann–Whitney
test, P > 0.1; Additional file 13), further supporting the
notion that elncRNA sequence is not constrained.
Similar results were obtained when substitution rates
were estimated by aligning mouse to orthologous human
sequence, rather than to rat sequence (Additional file 14).
Consequently, the differences in constraint observed
for plncRNAs and elncRNAs have persisted throughout
mammalian evolution. In summary, our findings reveal
that whilst plncRNA sequence and associated TIRs have
evolved under evolutionary constraint no such evidence is
detectable for intergenic elncRNAs or their TIRs.
elncRNA expression is associated with enhanced levels
of expression from neighboring protein-coding genes
The levels of expression of intergenic lncRNAs in general
correlate with the levels of transcription from adjacent
protein-coding genes [10,21,22,45]. Here we asked whether
this correlation was derived from either one or both of the
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tion was found to occur five times more frequently than
expected by chance (Materials and methods; permutation
test P < 0.005) in the vicinity of protein-coding genes
whose expression is higher (five-fold) in intermediate
erythroblasts than in any other tissue. By contrast, no
such enrichment was found for plncRNA loci (2% deple-
tion, permutation test P=0.35). Equivalent results were
obtained when the threshold of intermediate erythroblast
relative to other tissues expression was set to 2- or 10-fold
(data not shown).
To estimate the extent of the enhancement in protein-
coding gene expression observed in association with neigh-
boring lncRNA transcription we used publicly available
transcriptome data from three stages of erythroid develop-
ment to estimate the transcript levels of lncRNAs and
protein-coding genes in progenitor (BFU-e), early erythroid
(CFU-e) and intermediate erythroblast (Terr119+) cells
[28] (Materials and methods). We considered only those
transcripts whose expression could be detected in at least
one of the three developmental stages (41% of elncRNAs,
53% plncRNAs, and 85% mRNAs). As previously (Figure 3B),
the expression of elncRNAs tended to be restricted to
fewer cell types (Additional file 15).
We considered whether the abundance of elncRNAs
and plncRNAs correlated with the levels of transcripts from
adjacent protein-coding genes (Materials and methods).
Pairs of lncRNA loci and their closest neighboring protein-
coding genes that both showed detectable expression in
at least one erythropoietic stage were identified [28]
(Materials and methods; 17 elncRNAs and 28 plncRNAs),
together with a control set of 9,770 similarly identified
pairs of adjacent protein-coding genes. For each lncRNA
in a pair we identified the two developmental stages in
which its expression was either minimal or maximal,
and calculated the expression fold difference, Δ,f o ri t s
neighboring protein-coding gene at these two stages. If
there was no correlation between the expression levels of
adjacent genomic loci then Δ is expected to be distributed
around zero. The distribution of Δ values for genes that
are adjacent to plncRNA loci (median Δ =0.075) was
similar to Δ values for control pairs of adjacent protein-
coding loci (median Δ=0.076, two-tailed Mann–Whitney
test, P=0.97; Figure 5A). By contrast, despite being more
distant, on average, from their neighboring protein-coding
genes than are plncRNA loci (Additional file 3), Δ values
for the protein-coding genes adjacent to elncRNA loci
were, on average, 6.6-fold higher (median Δ=0.50, two-
tailed Mann–Whitney test, P<0.05; Figure 5A).
This increased expression of protein-coding genes lying
near to elncRNA loci may reflect regional changes in
chromatin that affect both coding and noncoding loci
[46] or could be due to a specific association between
transcription of the elncRNA and the nearest protein-
coding gene in its vicinity. To distinguish between these
possibilities, we also calculated Δ for protein-coding genes
lying adjacent to the nearest neighbor. We found that
expression levels of these ‘next-but-one’ genes were not
A
0
0.10
0.20
enh-TIR prom-TIR AR
NS
***
m
o
u
s
e
-
r
a
t
 
s
u
b
s
t
i
t
u
t
i
o
n
 
r
a
t
e
0.10
0.15
0.20
elncRNA plncRNA AR
NS
*
B
0.10
0.15
0.20
0.25
exon intron AR
**
NS
C
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elncRNA TIRs (median delncRNA-TIR=0.161, green) and plncRNA TIRs (median dplncRNA-TIR =0.127, blue), and for neighboring putatively neutrally
evolving sequence (ancestral repeats (ARs), white). Horizontal dashed line represents the neutral expectation (median dAR=0.165). (B) Mouse-rat
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two-tailed Mann–Whitney test, P=0. 27 ).Tova li da teth e
results obtained from this genome-wide analysis we used
quantitative PCR (qPCR) to investigate the association in
expression between 10 protein-encoding RNAs and
their genomically proximal 5 plncRNA or 5 elncRNA
loci (Figure 5B,C; Additional file 16). The correlation
between the fold-change in expression of these elncRNA
loci and their neighboring protein-coding genes (Pearson
R= 0.82) is considerably higher than that for pairs of
plncRNA loci and their adjacent protein-coding genes
(Pearson R=0.05), consistent with our genome-wide
observation.
We conclude that while the restricted spatial and
temporal expression of elncRNAs is associated with en-
hanced expression of its neighbors, no such correlation
can be found for the broadly expressed plncRNA loci.
Discussion
We recently found that that some intragenic lncRNAs
originate from active enhancers lying within protein-
coding genes [20]. These unidirectional intragenic lncRNAs
(named meRNAs) use the splicing and polyadenylation
signals of the protein-coding hosts [20] to produce
stable, polyadenylated lncRNAs. Like their intragenic
counterparts, intergenic enhancers are also known to
be associated with the transcription of both bidirec-
tional as well as unidirectional noncoding RNA tran-
scripts [17-19]. The earlier reports on the association
between intergenic lncRNA expression and enhanced
levels of neighboring protein-coding genes [10,21,22,45]
together with this finding led us to hypothesize that a
relatively high, yet undetermined, proportion of intergenic
lncRNAs may similarly originate from active intergenic
enhancers.
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lncRNAs and, using recent nanoCAGE technology,
accurately identified their transcriptional start sites.
This enabled us to subclassify these lncRNAs as arising
from promoters (plncRNAs, enriched for H3K4me3
over H3K4me1) or enhancers (elncRNAs, enriched for
H3K4me1 over H3K4me3) based on the chromatin
signatures of their TIRs. Unexpectedly, we found that
approximately half of these intergenic lncRNAs are tran-
scribed from enhancers rather than promoters. Importantly,
it is the ratio between H3K4me1 and H3K4me3 chromatin
marks that distinguishes enhancer- from promoter-
like sequences: most TIRs have both chromatin marks
(Figure 1) and three-quarters of the TIRs associated with
the intergenic enhancers studied here were (to some
extent) modified by H3K4me3. We propose that to
subclassify intergenic lncRNAs in combination with
high resolution maps of H3K4me1 and H3K4me3, the
data derived from the same sample that are required to
accurately distinguish between these two classes of lncRNAs
are (i) high depth poly(A)-selected RNA sequencing,
which is needed to faithfully build long transcript models,
(ii) nanoCAGE sequencing, which is required to accurately
define the 5′ ends of transcripts, and (iii) DNase 1 hyper-
sensitive site sequencing, which allows the identification
of regions of open chromatin that often harbor functional
cis-elements.
Our studies show that plncRNAs and elncRNAs differ
substantially in several properties, a distinction that should
now facilitate the design of targeted experiments seeking a
mechanistic understanding of the biological role of lncRNA
transcription, a key question in the field. Despite their dif-
ferent origins, plncRNAs and elncRNAs differ substantially
in their levels and tissue or cell expression profiles and in
their sequence conservation during evolution. However,
they are indistinguishable in terms of their lengths or their
numbers of exons or their transcriptional directionality.
Previous work has shown that expression of intergenic
lncRNAs in general is associated with enhanced expression
of their neighboring protein-coding genes, both through
genome-wide [10,21,22] and locus-specific analyses [22,23].
Here we show that this is a feature specific to elncRNAs
and not plncRNAs.
The clear difference in the selective pressures that have
acted on elncRNA and plncRNA TIRs or loci suggests
that, if functional, transcription (or transcripts) of the two
classes of lncRNAs may have distinct roles. Importantly,
the neutral, or near-neutral, evolution of elncRNAs and
the evidence of constraint found for plncRNAs imply that
the two lncRNA classes are distinct: a locus will rarely be
an elncRNA in one tissue and a plncRNA in another.
Enhancer-like lncRNA TIRs and sequences are poorly
conserved during mammalian evolution, which is entirely
consistent with previous reports of rapid turnover of DNA
sequence at enhancers during evolution [47,48]. This
might suggest that similarly to their intragenic counter-
parts [20], promoter directionality of intergenic elncRNAs
may derive from cis-acting signals found in their genomic
vicinity and does not reflect global preservation of func-
tional motifs within elncRNA transcripts. The distributions
of splice sites and polyadenylation signals around a
transcription start site have recently been shown to be
important in determining the directionality and stability of
extended RNA transcripts [49]. Due to the relatively small
number of lncRNAs annotated in this experiment, our
data are insufficient to address this issue for erythroblast
lncRNA loci.
By contrast, plncRNA promoters and the associated
exons in their processed RNAs appear to have evolved
under selective constraint, accumulating significantly
fewer substitutions than neutral sequence, a signature
of potential function. Constraint on plncRNA transcribed
sequence occurs predominantly in the exons, indicating
that it is the mature, spliced form, rather than the precur-
sor molecule (or more simply the act of transcription) that
mediates any plncRNA function. It should be borne
in mind that plncRNA constraint is modest, only approxi-
mately 20% or approximately 5% of deleterious substitu-
tions are predicted to have been purged from their TIRs
or exons, respectively. The latter constraint suggests
that either a small fraction of plncRNAs or a relatively
small portion of their sequence has conserved (potentially
functional) roles [4,6-8].
Conclusions
In summary, we have shown that the regulatory elements
at the origin of intergenic lncRNAs, defined based on
chromatin status, allow the distinction between two
classes of transcripts that may have different biological
functions. This categorization of previously indistinguish-
able lncRNAs will allow more specific genome-wide inves-
tigation of their properties, accelerating our understanding
of their potential biological roles and the molecular mecha-
nisms by which they operate.
Materials and methods
Primary cells
Biological material for the preparation of high-throughput
sequencing libraries was obtained from primary erythroid
cells isolated from spleens of phenylhydrazine-treated mice
(C57BL/6) [50] using anti-Ter119 microbeads (Miltenyi
Biotec { Bergisch Gladbach, Germany }) as previously de-
scribed [51]. Total RNA used for qPCR was extracted
from colony-forming unit erythroblasts (CFUEs) and
terminally differentiated primary erythroid (Ter119
+)
cells isolated from E12.5 mouse fetal livers. To enriched
samples, cells were expanded in vitro for 4 days in StemPro
media (Invitrogen, Carslbad, CA, USA) supplemented with
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and dexamethasone (1 μM) at 37°C, 5% CO2,f o l l o w e d
by magnetic-activated cell sorting depletion of Ter119
+
cells and FACS sorting of Ter119
neg/CD44
hi progenitor
cells (CFUEs) - adapted from Chen et al. [52]. To obtain
Ter119
+ terminally differentiated erythroid cells from
the same culture, Ter119
neg/CD44
hi progenitor cells were
FACS sorted as above and cultured StemPro media
(Invitrogen) supplemented with erythropoietin (5 U/ml)
without stem cell factor and dexamethasone for for 44 h
(37°C, 5% CO2).
Library preparation
Total RNA was extracted using Tri-reagent, DnaseI treated
with Turbo DnaseI (Ambion Carlsbad, CA, USA). Good
quality RNA (RIN value >9) was poly(A) selected using the
PolyATract mRNA isolation system (Promega, Madison,
WI, USA) according to the manufacturer’s instructions.
Poly(A)+RNA was further depleted of globin transcripts
using GlobinClear (Ambion). Libraries for RNA-Seq were
prepared and sequenced (51 bp paired-end reads) using
the standard Illumina protocol. Strand-specific NanoCAGE
libraries from poly(A)-selected RNA were prepared and
sequenced (100 bp paired-end reads) by Source Bioscience.
(Nottingham, UK).
Chromatin immunoprecipitation on primary erythoid
cells was performed as previously described [20] using the
following antibodies: anti-H3K4me1 (Millipore, 07–436,
Billerica, MA, USA)) and anti-H3K4me3 (Millipore,
05-745R clone 15-10C-E4). ChIP-Seq libraries were
prepared and sequenced (50 bp paired-end reads) using
the standard Illumina protocol.
Read mapping and next generation sequencing
data analysis
ChIP-seq and DNAse I hypersensitive site (DHS)-seq
data were aligned to the mm9 mouse genome build using
bowtie (version 0.12.3) [53,54] with the -m reporting option
set to 2. To exclude over-amplified products from these
data sets, read pairs that map to the identical genomic
location were collapsed into a single representative set of
reads. Peaks of DNAse I enrichment were called using
Seqmonk (version 0.21.1) [55] using the following parame-
ters: depth cutoff=20; minimum size=50 and merge
distance=100. The resulting peak calls were intersected
with problematic copy number regions in the mm9
genome using intersectappend.pl and used to generate
a MIG database [56] for manual inspection of called
peaks. A final set of robust DHS peaks were exported
from the MIG database excluding problematic copy
number regions with a normalized enrichment value of
at least 1.
Globin-depleted poly A-selected RNA sequencing reads
were mapped to the mouse genome (mm9) with TopHat
[57]. Splice junctions from ENSEMBL 68 [58] were
provided to facilitate read mapping across known mouse
transcript splice junctions. Transcripts were assembled
de novo using Cufflinks (version 1.3.0) [43] with pa-
rameters –min-frags-per-transfrag 5 -m 150 -s 30 -u.
ENSEMBL 68 [58] gene annotations were used as
reference.
Prior to analysis of the nanoCAGE data the first 21 bp
of the read 1 fastq file was trimmed to remove the nanoC-
AGE specific primer. The resultant paired-end reads were
aligned using TopHat (1.1.4b). Aligned reads were split
into forward and reverse strands using Samtools [59]. For
visualization in genome browsers the position of the first
mapped base on read 1 was then used to generate the
density of transcription start site positions in a moving
window of 100 bp with a 10 bp increment of movement,
to produce wig tracks of signal distribution.
Annotation of transcriptional initiation regions
We used globin-depleted poly(A)+selected nanoCAGE
sequencing reads to annotate genome-wide transcriptional
start sites and promoters as described elsewhere [25].
Briefly, we extracted the 5′ end position of each read
(hereafter termed transcriptional start site). Transcrip-
tional start sites closer than 20 bp and derived from
the same strand were clustered. Clusters within 400 bp
of each other and on the same strand were considered
to be part of the same TIR. TIRs supported by fewer
than 5 nanoCAGE reads were discarded, leaving a set
of 64,619 TIRs.
For each transcript assembled using cufflinks, we
identified reads supporting any of the 64,619 TIRs that
overlapped (by >1 nucleotide) their associated transcribed
sequence (exons). We excluded from our analysis TIRs that
did not overlap (by >1 nucleotide) a DNAse I hypersensitive
site region annotated as described above. We associated
14,689 transcripts to the remaining high confidence 11,131
TIRs. For single exonic transcripts only those with a
putative TIR upstream of only one of the possible puta-
tive transcriptional starts were considered. For these
transcripts the strand was imputed based on the strand
information for their respective TIRs. This resulted in
the annotation of 11,689 transcripts. We considered
transcripts overlapping (>1 nucleotide) a protein-coding
gene annotation (ENSEMBL build 68) as intragenic
(11,036 transcripts). The protein-coding potential of
intergenic transcripts longer than 200 nucleotides was
analyzed using CPC [33]. Intergenic transcripts longer
than 200 nucleotides with no protein-coding potential
according to CPC (‘noncoding’) and no overlap with
pseudogene annotations (ENSEMBL build 68) were anno-
tated as lncRNAs (391 lncRNAs). The relative enrichment
of H3K4me1 and H3K4me3 around eachTIR or DHS was
calculated as previously described using comparably sized
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distribution of high-throughput sequencing data over
TIRs (Figure 1) and all DHSs (Additional file 5) was
generated using the in-house perl script Hotpile.pl and
visualized in R using the gplots library. The cumulative
distribution of high-throughput sequencing data over all
of the enhancer and promoter populations (Figure 2B,C)
and elncRNA and plncRNA TIRs (Figure 2D,E) were
generated using the in-house perl script Quantpile.pl
and displayed in Microsoft Excel. The strand-specific
poly(A)- transcriptional data were split into plus and
minus strand transcription using Samtools. The strand-
specific enrichment of aligned reads around each class of
TIR was determined using the in-house PERL script
SRP.pl. The enrichment of poly(A) +aligned reads was
determined as for the poly(A)- without splitting the data
into forward and reverse strand as this RNA-seq library
was non-directional.
Nucleotide constraint
Nucleotide constraint between mouse and rat locus, exon,
intron or TIR was estimated as described previously [8].
Pairwise substitution rates between mouse and rat or
human genomic regions were estimated using BASEML
from the PAML package with the REV substitution model
[60]. The substitution rate of the region of interest was
compared to the rate observed for non-overlapping
adjacent (<500 kb) ancestral repeats (inserted before the
primate and rodent split) with similar G+C content [8].
Gene expression
Mouse protein-coding transcript annotations were down-
loaded from ENSEMBL (build 68). Cufflinks (default
parameters) was used to estimate the expression of protein-
coding genes and lncRNAs using the poly(A)-selected RNA
sequencing from intermediate erythroblast (Ter119+) and
mapped reads from mouse ENCODE project that were
publicly available [44] (Additional file 12).
We estimated the median expression and tissue specifi-
city across all mouse tissue/cell lines (Additional file 12).
We calculated tissue specificity (TS) values for each tissue
and each locus. TS is defined as the fractional expression of
a locus in one tissue relative to the sum of its expression in
all tissues. The maximum TS value (maxTS) for a locus
thus provides an indicator of tissue specificity, with higher
values reflecting more tissue-specific expression [61].
Association between intergenic lncRNA and neighboring
gene expression
The Genome Association Tool (GAT) [62] was used to
assess the significance between lncRNA and expression of
their neighboring protein-coding genes. For each protein-
coding gene we defined its territory as the genomic region
containing all nucleotides that are closer to the gene
than they are to its most proximal up- and downstream
protein-coding genes. We estimated the enrichment in
lncRNA transcription in the territories of genes that were
expressed more highly (2×, 5× and 10×) in intermediate
erythroblasts to what would be expected based on random
placement of intervals with a similar size across the
intergenic mouse genome.
We downloaded total RNA sequencing reads [28] from
the Gene Expression Omnibus (GEO) [63] and mapped the
reads to the mouse reference genome (mm9) as described
above. We masked the α-globin locus because it accounts
for a disproportionate fraction of intermediate erythroblast
RNA. The number of mapped reads in CFUEs (colony-
forming unit erythroid) and BFUEs (burst-forming uni-
terythroid) was down sampled to the size of the Ter119+
library, which had the lowest number of mapped reads,
by randomly sampling. To estimate normalized gene
expression across the three stages of erythropoiesis, we
defined a set of constitutive exons for protein-coding gene
annotations (ENSEMBL 68) and lncRNAs and quantified
the number of sequencing reads mapping to constitutively
expressed regions of these transcripts in each of this
regions. To allow the comparison of gene expression
between species, read counts were normalized using TMM
(edgeR package) [64]. Briefly, to estimate the normalized
library size for each species, it was assumed that 60% of
expressed genes were transcribed at similar levels in the
two species. The normalized library sizes were used to
calculate the expression level (as total FPKM) of each
gene across the three stages of erythropoiesis. Each locus
was paired with its genomically closest protein-coding
gene. Only pairs where both loci were expressed in at least
one erythropoietic stage were considered.
Protein-coding genes and their closest neighboring five
elncRNAs and five plncRNAs were selected from the total
number of identified candidates in each class (124 and 115,
respectively). RNA was extracted from primary mouse
CFUEs and terminally differentiated (Ter119
+) cells using
TriReagent (Sigma, St. Louis, MO, USA). RNA was DNase
treated (Ambion), and reverse transcribed using SuperScript
III (Invitrogen). Expression of each elncRNA/plncRNA
and its nearest protein-coding gene was analyzed by qPCR
using SYBR Green (Applied Biosystems, Carlsbad, CA,
USA). Expression analysis was performed in three inde-
pendent biological replicates, and normalized to expression
of Rn18s (ribosomal subunit 18 s). All reactions were
performed in triplicate on each template using the
StepOnePlus thermocycler (Applied Biosystems). The
sequences of the primers used are available in Additional
file 17.
Data availability
All data used for this analysis are accessible through GEO
accession number GSE49460.
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Additional file 1: Genomic coordinates of intermediate erythroblast
expressed transcripts.
Additional file 2: Genomic coordinates of transcriptional initiation
regions (TIRs) associated with intermediate erythroblast expressed
transcripts.
Additional file 3: Relationship between TIRs and transcripts.
Additional file 4: The number of tags supporting transcription
initiation correlates with its expression. The logarithm of the number
of reads supporting a given transcriptional initiation region (TIR, x-axis)
and the expression (log(FPKM), y-axis) of its associated transcripts are
significantly correlated (Pearson correlation R =0.44, P<2×1 0
-16).
Additional file 5: Contrasting epigenetic landscapes at
transcriptional start sites of promoter or enhancer-associated
lncRNAs in mouse intermediate erythroblasts. (A) All detected mouse
erythroid DNAse I hypersensitive sites (DHSs) were sorted based on the
difference in enrichment of H3K4me1 and H3K4me3. The same sort order
was used for all panels displayed here, and levels of H3K4me3 and
H3K4me1 are depicted as red and blue triangles, respectively. Each panel
shows the distribution of signal in a 4 kb window centered on the
middle of each DHS. The enhancer and promoter populations are
demarcated by blue and red boxes, respectively. The active chromatin
mark H3K27ac and NanoCage mapped sources of transcription are
associated with both the enhancer and promoter populations, whereas
the signal for the tissue-specific transcription factor Gata1 is predominately
associated with the enhancer class as expected. (B,C) Chromatin profiles
normalized for number of peaks associated with the mouse Ter119+ promoters
and enhancers, respectively. (D,E) Chromatin profiles normalized for number
of peaks associated with the mouse Ter119+ plncRNAs and elncRNAs TIRs,
showing their promoter and enhancer profiles, respectively. Color coding
indicating each chromatin mark is shown below.
Additional file 6: Classification of TIRs.
Additional file 7: Examples of previously annotated meRNAs that
were also identified in this study. High resolution maps of DNAse I
(black), H3K4me1 (dark blue), H3K4me3 (light blue), Gata1 (red),
nanoCAGE (minus stand, dark green; plus strand, light green) and
RNA-seq (orange) across mouse (A) Nprl3 (chr11:32123000 to 32175999),
(B) Ccdc88c (chr12:102134000 to 102272999), (C) Inpp5d (chr1:89519000
to 89642999), (D) Dnttip1 (chr11:32045920 to 32245919) and (E) Hagh
(chr17:24962000 to 25015999). Grey represents the regions previously
annotated as enhancer-associated alternative first exons [20].
Additional file 8: Genomic coordinates of intermediate erythroblast
expressed elncRNAs.
Additional file 9: Genomic coordinates of intermediate erythroblast
expressed plncRNAs.
Additional file 10: Distance between pairs of intermediate
erythroblast expressed transcripts. Distance in kilobase pairs between
the transcriptional start sites of pairs of genomically neighboring
protein-coding gene transcripts (grey); elncRNAs and neighboring
protein coding genes (green); and, plncRNAs and neighboring
protein-coding genes (blue). ***P < 0.001; NS, not significant.
Additional file 11: Cumulative poly(A) depleted RNA sequencing
reads around transcriptional start sites. Total number of poly(A)- RNA
sequencing reads (y-axis) associated with the transcriptional start sites of
protein-coding gene, plncRNA and elncRNA meta-genes’ transcriptional
start sites (±200 bp, x-axis) originating from the sense (blue) and
antisense(red) direction. Arrow indicates direction of transcription.
Additional file 12: Intergenic lncRNA expression across different
mouse tissues and cell types, including intermediate erythroblasts
(Ter119+).
Additional file 13: Exons and introns of elncRNAs have not been
selectively constrained during rodent evolution. Mouse-rat nucleotide
substitution rates for elncRNA exons, introns and neighboring putatively
neutrally evolving sequence (ancestral repeats, ARs) are shown. NS, not
significant.
Additional file 14: plncRNA but not elncRNA loci are selectively
constrained over mammalian evolution. (A) Mouse-human nucleotide
substitution rates for protein-coding (PC) transcriptional initiation regions
(TIRs), lncRNA TIRs and neighboring putatively neutrally evolving sequence
(ancestral repeats, ARs). (B) Mouse-human nucleotide substitution rates for
transcribed loci of protein-coding genes (PC) and lncRNAs and for ARs.
(C) Mouse-human nucleotide substitution rates for elncRNA and plncRNA TIRs.
(D) Mouse-human nucleotide substitution rates for elncRNA and plncRNA
transcribed loci. ***P<0.001;* *P<0.01;* P< 0.05; NS, not significant.
Additional file 15: Expression of elncRNAs, plncRNAs and
protein-coding genes through three stages of erythropoiesis.
Percentage of loci with detectable expression in one (white), two (grey) or
three (black) erythropoiesis stages; data from [26].
Additional file 16: Fold-change in expression.
Additional file 17: Primer sequence.
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bp: Base pair; CFUE: Colony forming unit erythroblast; ChIP-seq: Chromatin
immunoprecipitation followed by sequencing; DHS: DNAse I hypersensitive
site; elncRNA: Intergenic enhancer-associated lncRNA; eRNA: Enhancer-associated
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